Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Crowley

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Blood|July 23, 2011
Could CR mean cure?Bart Barlogie, John Crowley
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Small randomized trialsMary Redman, John Crowley
Blood|October 23, 2012
Prognostic implications of cumulative dosing in total therapy 3Bart Barlogie, John Crowley
Clinical Advances in Hematology & Oncology : H&O|July 4, 2007
Clinical trial designs for multiple myelomaAntje Hoering, John Crowley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2017
Biomarker-Stratified Phase III Clinical Trials: Enhancement with a Subgroup-Focused Sequential DesignShigeyuki Matsui, John Crowley
JAMA|March 17, 2005
Is there any hope for vitamin E?B Greg Brown, John Crowley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2011
DNA cytometry testing for cervical cancer screening: approaches and reporting standards for new technologiesGraham A Colditz, John Crowley
Statistics in Medicine|June 19, 2015
Using a latent class model to refine risk stratification in multiple myelomaPingping Qu, Bart Barlogie, John Crowley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Multiple Histology Phase II TrialsMichael Leblanc, Cathryn Rankin, John Crowley
Statistical Methods in Medical Research|July 4, 2002
Partitioning and peeling for constructing prognostic groupsMichael LeBlanc, Joth Jacobson, John Crowley
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Blood|July 23, 2011
Could CR mean cure?Bart Barlogie, John Crowley
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Small randomized trialsMary Redman, John Crowley
Blood|October 23, 2012
Prognostic implications of cumulative dosing in total therapy 3Bart Barlogie, John Crowley
Clinical Advances in Hematology & Oncology : H&O|July 4, 2007
Clinical trial designs for multiple myelomaAntje Hoering, John Crowley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2017
Biomarker-Stratified Phase III Clinical Trials: Enhancement with a Subgroup-Focused Sequential DesignShigeyuki Matsui, John Crowley
JAMA|March 17, 2005
Is there any hope for vitamin E?B Greg Brown, John Crowley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2011
DNA cytometry testing for cervical cancer screening: approaches and reporting standards for new technologiesGraham A Colditz, John Crowley
Statistics in Medicine|June 19, 2015
Using a latent class model to refine risk stratification in multiple myelomaPingping Qu, Bart Barlogie, John Crowley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Multiple Histology Phase II TrialsMichael Leblanc, Cathryn Rankin, John Crowley
Statistical Methods in Medical Research|July 4, 2002
Partitioning and peeling for constructing prognostic groupsMichael LeBlanc, Joth Jacobson, John Crowley
Pageof 18